Academic Journals In Translational Medicine|OMICS International|Translational Medicine

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Academic Journals In Translational Medicine

Academic journals are periodicals in which researchers publish their findings, mostly the recent ones. Academic journals are typically peer-reviewed journals that publish theoretical discussions and articles that critically review already published work. Academic journals serve as an important forum for researchers and academicians from where they can access important information about recent developments in their field. These journals are the first choice for any in-depth examination of an issue related to science. Science as we know is scarcely imaginable without the academic journal. OMICS Group International Journals fall under the academic category as they strictly adhere to peer-review process and follow the format by publishing mostly the original work. Translational medicine is an increasingly important field designed to bridge the gap between basic science and clinical care. Academic institutions, industry, and other health organizations commit billions of dollars annually for the development of translational medicine programs. These efforts are aimed at integrating knowledge gained through basic science research and clinical practice to provide effective and novel strategies for the diagnosis, prevention, and treatment of common diseases. The human genome project draft sequence, published in 2001, revolutionized the scope and capabilities of translational medicine by enabling researchers to study the entire structure and function of the human genome. This project eventually led to the development of new technologies such as high-throughput techniques and new fields like genomics, proteomics, and metabolomics. Taken together, these advances ushered in a new era of genome-based studies that may elucidate the molecular mechanisms behind diseases such as cancer. In addition, they introduced the possibility of providing personalized medical care that draws upon an individual’s genetic information to optimize patient management. (Min Li, Translational Medicine: Are we Ready for the Prime Time?)
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on January, 2021